Cordlife Group Limited 每股年股息為 0.00,收益率為 0.00%。股息每 每年 支付,最後除權日為 May 6, 2022。
股息收益率
年度股息
除息日
0.00%
$0.00
May 6, 2022
付款頻率
派息比例
每年
0.00%
股利歷史
除息日
現金金額
記錄日期
付款日
May 6, 2022
$0.009
May 9, 2022
May 27, 2022
May 7, 2021
$0.009
May 10, 2021
May 28, 2021
Jun 17, 2020
$0.01
Jun 18, 2020
Jul 3, 2020
Apr 30, 2019
$0.004
May 2, 2019
May 17, 2019
股利圖表
CLIFF 股利
CLIFF 股息增長(年增率)
關鍵數據
前收市價
$0.0689
開盤價
$0.1018
當日範圍
$0.0689 - $0.1018
52週區間
$0.0689 - $0.1722
交易量
2.1K
平均成交量
180
每股盈餘 (TTM)
-0.04
股息收益率
--
市值
$17.6M
什麼是 CORDLIFE GROUP LIMITED?
Cordlife Group Ltd. is an investment holding company, which engages in the provision of cord blood and cord lining banking services. The firm's principal activities involve investment holding and the provision of cord blood banking services. Its segments include Banking and Diagnostics. The Banking segment comprises of the banking of samples such as cord blood, cord lining and cord tissue. Cord blood, cord lining and cord tissue are collected, processed, and stored in the various laboratories. The Diagnostics segment comprises diagnostic testing such as non-invasive prenatal testing service, newborn metabolic screening, newborn genetic screening, and pediatric vision screening services. Its subsidiaries include Cordlife (Hong Kong) Limited, Cordlife Stem Cell Technology Limited, Healthbaby Biotech (Hong Kong) Co., Limited, Cordlife Technologies Pte. Ltd., CS Cell Technologies Pte. Ltd., Stemlife Berhad, and Shanghai Cordlife Biomedical Research Co., Ltd.